Please assess the completion status of the following clinical trial:

Trial Title: Testing if BCG (Bacille Calmette-Guérin) Vaccination Can Induce Innate Immune Training in Adult People Above 50 Years of Age in Guinea-Bissau

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* adults above 50 years of age~Exclusion Criteria:~* Participants who received BCG in the last 10 years will be excluded.~* Adults who were mild to severe ill in the last 2 week will be excluded.~* Adults how have been in contact with the health system (hospital or health center) for the last 14 days will be excluded.~* People that show signs of overt disease will not be enrolled, but treated according to local standards and invited back when better.~* If the person has any sign of TB, they will excluded and be referred to the TB clinic for further investigations and treatment.~* All participants will be tested for HIV. If the test is positive, they will have an opportunity to talk with a psychologist, and we will refer them to the HIV clinic. HIV positive persons will be excluded from the present study.

- Gender: ALL
- Minimum Age: 50 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Intervention arm (Type: EXPERIMENTAL): Intervention arm, these participants will receive BCG vaccination.
- Placebo arm (Type: PLACEBO_COMPARATOR): The placebo arm will receive BCG solvent.

Based on this trial design, predict the completion outcome and termination type (if applicable).